GRMN
53
3
MCD
52
3
ECL
54
5
AES
47
4
EMR
57
7
SPG
45
2
GD
42
4
AZO
46
3
AIG
38
5
VTR
44
4
SLG
37
6
ADP
57
2
BAC
38
3
EQR
33
6
FIS
43
5
RCL
74
5
KMI
69
8
UNP
38
5
CHD
34
7
VIX
41
-11
GRMN
53
3
MCD
52
3
ECL
54
5
AES
47
4
EMR
57
7
SPG
45
2
GD
42
4
AZO
46
3
AIG
38
5
VTR
44
4
SLG
37
6
ADP
57
2
BAC
38
3
EQR
33
6
FIS
43
5
RCL
74
5
KMI
69
8
UNP
38
5
CHD
34
7
VIX
41
-11
Financhill
Back

CareTrust REIT 10K Form

Sell
42

CTRE
CareTrust REIT

Last Price:
$27.35
Seasonality Move:
-5.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTRE News And Ratings

See the #1 stock for the next 7 days that we like better than CTRE

CTRE Financial Statistics

Sales & Book Value

Annual Sales: $198.6M
Cash Flow: $64.4M
Price / Cash Flow: 18.63
Annual Sales: $14.15
Price / Book: 2.12

Profitability

EPS (TTM): 0.72000
Net Income (TTM): $99.2M
Gross Margin: $189M
Return on Equity: 5.79%
Return on Assets: 4.2%

CareTrust REIT Earnings Forecast

Key CareTrust REIT Financial Ratios

  • The Gross Profit Margin over the past 12 years for CTRE is 95.17%.
  • The Selling, General & Administrative Expenses for CTRE have been equal to 10.52% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 76.08% of Operating Income.
  • The Net Earning history of CTRE is 27.06% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

CareTrust REIT Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care REITs
Sector: Real Estate
Current Symbol: CTRE
CUSIP: 14174T
Website: caretrustreit.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 3.96
Quick Ratio: 3.8

Price-to-Earnings

Trailing P/E Ratio: 54.72
Forward P/E Ratio: 18.4

CTRE Technical Analysis vs Fundamental Analysis

Sell
42
CareTrust REIT (CTRE) is a Sell

Is CareTrust REIT a Buy or a Sell?

  • CareTrust REIT stock is rated a Sell
    The current CareTrust REIT [CTRE] share price is $27.36. The Score for CTRE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.